| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/03/2005 | US6887673 Containing light chain and a heavy chain peptide; anticarcinogenic agent |
| 05/03/2005 | US6887672 Anti-equine Fc epsilon receptor alpha chain antibodies and methods to detect IgE |
| 05/03/2005 | US6887670 For drug screening; solid phase synthesis; fusion proteins; genetic engineering |
| 05/03/2005 | US6887668 Using high-resolution buffer; allows reduced local Joule heating, 10-100 fold electric fields, resulting in high speed runs, improved resolution, high reproducibility; well suited for automation |
| 05/03/2005 | US6887664 Thermal cycling protocol for nucleic acid amplification uses two primers with different thermal melting temperatures |
| 05/03/2005 | US6887662 Oligonucleotides and assemblies thereof useful in the detection of the presence or absence of target nucleic acid sequences in a sample |
| 05/03/2005 | US6887661 Recombinant bHLH-PAS/JHR polypeptide and its use to screen potential insecticides |
| 05/03/2005 | US6887660 Detecting cancer in humans; obtain sample, incubate with binding protein, detect bound proteins or polypeptides, presence of bound protein indicates cancer |
| 05/03/2005 | US6887659 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis |
| 05/03/2005 | US6887483 Non-toxic mutants of pathogenic gram-negative bacteria |
| 05/03/2005 | US6887473 Administering as antitumor, antimetastasis, antiinflammatory, or anticarcinogenic agent |
| 05/03/2005 | US6887472 That do not cause anaphylaxis, antigenic fusion proteins of given amino acid sequence, of a CH3 domain of an immunoglobulin (IgE) molecule; allergy vaccines; vaccine test methods in dogs |
| 05/03/2005 | US6887468 Antibody kits for selectively inhibiting VEGF |
| 05/03/2005 | US6887467 Double mutants of dihydrofolate reductase and methods of using same |
| 05/03/2005 | US6887463 Recombinant viral vector encoding a human very low density lipoprotein (VLDL) receptor, operatively linked to regulatory sequences directing expression in a hepatocyte; familial hypercholesterolemia or hyperlipidemia |
| 05/03/2005 | CA2303408C Chromosomal mutagenesis in pichia methanolica |
| 05/03/2005 | CA2147623C Novel p-selectin ligand protein |
| 05/03/2005 | CA2128215C Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 04/30/2005 | CA2553542A1 Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of nad |
| 04/28/2005 | WO2005038054A1 METHOD OF MEASURING THE EFFICACY OF siRNA MOLECULES |
| 04/28/2005 | WO2005038050A1 Method for identification of suitable fragmentation sites in a reporter protein |
| 04/28/2005 | WO2005038040A2 Methods and compositions for altering seed phenotypes |
| 04/28/2005 | WO2005038035A2 Methods for producing and using in vivo pseudotyped retroviruses |
| 04/28/2005 | WO2005038034A2 Plant transcriptional regulators of abiotic stress |
| 04/28/2005 | WO2005038033A2 Cloning of cytochrome p450 genes from nicotiana |
| 04/28/2005 | WO2005038032A1 Axmi-010, a delta-endotoxin gene and methods for its use |
| 04/28/2005 | WO2005038031A1 Expression vector for secreting antibody fragment using e. coli signal sequence and method for mass-producing antibody fragment |
| 04/28/2005 | WO2005038028A1 Poxvirus vector encoding retrovirus (eg hiv) and cytokine |
| 04/28/2005 | WO2005038027A1 Transgenic nonhuman mammal |
| 04/28/2005 | WO2005038026A1 Method of typing mutation |
| 04/28/2005 | WO2005038025A1 Nucleic acid extraction method |
| 04/28/2005 | WO2005038024A1 A method of screening for protein secreting recombinant host cells |
| 04/28/2005 | WO2005038021A1 Novel transporter protein |
| 04/28/2005 | WO2005038020A1 Flp-mediated recombination |
| 04/28/2005 | WO2005038018A2 Cloning of cytochrome p450 genes from nicotiana |
| 04/28/2005 | WO2005038014A1 Isolation of stem cell-like cells and use thereof |
| 04/28/2005 | WO2005038013A1 Artisense oligonucleotides optimized for kidney targeting |
| 04/28/2005 | WO2005038006A2 Chimeric metabotropic glutamate receptors and uses thereof |
| 04/28/2005 | WO2005038005A2 Shc proteins as therapeutic targets in proliferative diseases |
| 04/28/2005 | WO2005038004A2 Method to product para-hydroxybenzoic acid in the stem tissue of green plants by using a tissue-specific promter |
| 04/28/2005 | WO2005038003A2 Compositions and methods for generation of positive and negative selection vectors |
| 04/28/2005 | WO2005038002A2 Site-specific incorporation of redox active amino acids into proteins |
| 04/28/2005 | WO2005038001A2 Improved transgenesis by sperm-mediated gene transfer |
| 04/28/2005 | WO2005037994A2 Transgenic rodents selectively expressing human b1 bradykinin receptor protein |
| 04/28/2005 | WO2005037993A2 Promoters functional in plant plastids |
| 04/28/2005 | WO2005037991A2 Interacts with ice1 and regulates cbf expression and freezing tolerance in arabidopsis |
| 04/28/2005 | WO2005037988A2 Nucleic acid-adsorbing porous membrane for separating and purifying nucleic acid and apparatus for separating and purifying nucleic acid |
| 04/28/2005 | WO2005037987A2 Isolated nucleotide sequences responsible for the tomato high pigment-1 mutant phenotypes (hp-1 and hp-1w) and uses thereof |
| 04/28/2005 | WO2005037911A2 Heterofunctional copolymers of glycerol and polyethylene glycol, their conjugates and compositions |
| 04/28/2005 | WO2005037870A1 Antibody and use of the same |
| 04/28/2005 | WO2005037864A1 Novel protein and production process and use thereof |
| 04/28/2005 | WO2005037863A2 Alternative splicing factors polynucleotides, polypeptides and uses thereof |
| 04/28/2005 | WO2005037856A2 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications |
| 04/28/2005 | WO2005037854A2 Immunogenic peptides |
| 04/28/2005 | WO2005037392A2 Method for the dissociation of the extracellular haemoglobin molecule of arenicola marina and the characterisation of the protein chains forming the molecule and the nucleotide sequences coding for said protein chains |
| 04/28/2005 | WO2005037323A2 Use of gro to treat or prevent inflammation |
| 04/28/2005 | WO2005037322A1 Oncogene therapeutic drug |
| 04/28/2005 | WO2005037321A1 Oncogene therapeutic drug |
| 04/28/2005 | WO2005037316A1 Method of inhibiting secretase activity |
| 04/28/2005 | WO2005037229A2 Methods and compositions for modulating gamete adhesion |
| 04/28/2005 | WO2005037226A2 Genetically engineered enteroendocrine cells for treating glucose-related metabolic disorders |
| 04/28/2005 | WO2005037222A2 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 04/28/2005 | WO2005037218A2 Lentiviral vector delivery of il-21 for treatment of cancer |
| 04/28/2005 | WO2005037211A2 Methods and compositions for the treatment of neurological disease |
| 04/28/2005 | WO2005037191A2 Expression of dominant negative transmembrane receptors in the milk of transgenic animals |
| 04/28/2005 | WO2005037053A2 High throughput screening of aptamer libraries for specific binding to proteins on viruses and other pathogens |
| 04/28/2005 | WO2005036953A1 Method of transforming plant and instrument for transforming plant to be used therein |
| 04/28/2005 | WO2005024061A3 Compounds and methods for modulation of dna replication |
| 04/28/2005 | WO2005024059A3 Methods for identifying compounds for inhibiting fever |
| 04/28/2005 | WO2005024033A3 Nucleotide sequences promoting the trans-membrane transport of nucleic acids |
| 04/28/2005 | WO2005023312A3 Methods for transfecting cells using dna minor groove binding agents |
| 04/28/2005 | WO2005017521A3 Techniques for recording signals |
| 04/28/2005 | WO2005014626A3 Recombinant human metapneumovirus and its use |
| 04/28/2005 | WO2005013889A3 Truncated fragments of alpha-synuclein in lewy body disease |
| 04/28/2005 | WO2005010165A3 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 04/28/2005 | WO2005010155A3 Methods of decoupling reaction scale and protein synthesis yield in batch mode |
| 04/28/2005 | WO2005007886A3 Method for displaying and selecting a protease molecule |
| 04/28/2005 | WO2005003371A3 Erk7 and erk8, novel diagnostic markers for cancer |
| 04/28/2005 | WO2005001133A3 Compositions and methods for high throughput construction and functional analysis of expression libraries |
| 04/28/2005 | WO2005001062A3 Modified vectors for organelle transfection |
| 04/28/2005 | WO2005001023A3 Method and carrier complexes for delivering molecules to cells |
| 04/28/2005 | WO2004099251A3 Compositions and methods for treatment of cryptococcosis |
| 04/28/2005 | WO2004098646B1 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 04/28/2005 | WO2004098531A3 Increased transduction using abc transporter substrates and/or inhibitors |
| 04/28/2005 | WO2004098492A3 Trans-golgi network-associated processes, methods and compositions related thereto |
| 04/28/2005 | WO2004096832A3 Novel antiangiogenic peptides |
| 04/28/2005 | WO2004095216A3 The symmetry relationships between pairs of connectrons |
| 04/28/2005 | WO2004093530A3 Generation of plants with altered oil content |
| 04/28/2005 | WO2004093529A3 Generation of plants with altered oil content |
| 04/28/2005 | WO2004090135A3 Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol |
| 04/28/2005 | WO2004082368A3 Improved plant transformation |
| 04/28/2005 | WO2004076618A8 Genetically modified non-human mammals and cells |
| 04/28/2005 | WO2004064765A3 Herpesvirus amplicon particles |
| 04/28/2005 | WO2004063329A3 Modulation of pten expression via oligomeric compounds |
| 04/28/2005 | WO2004053062A3 Bentgrass event asr-368 and compositions and methods for detection thereof |
| 04/28/2005 | WO2004053055A3 Transgenic maize with enhanced phenotype |
| 04/28/2005 | WO2004052309A3 Modulation of stat 6 expression |
| 04/28/2005 | WO2004047750A3 Modulation of notch2 expression |
| 04/28/2005 | WO2004044160A3 Muc1 interference rna compositions and methods derived therefrom |
| 04/28/2005 | WO2004029224A3 Methods of engineering spatially conserved motifs in polypeptides |